David E. Jorden
Board Member
Nuo Therapeutics, Inc. (AURX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Nuo Therapeutics, Inc. (AURX) | Chief Executive and Financial Officer | $225,000 | $225,000 |
| 2023 | Nuo Therapeutics, Inc. (AURX) | Chief Executive and Financial Officer | $225,000 | $225,000 |
| 2022 | Nuo Therapeutics, Inc. (AURX) | Chief Executive and Financial Officer | $168,750 | $170,536 |
| 2021 | Nuo Therapeutics, Inc. (AURX) | Chief Executive and Chief Financial Officer | — | — |
| 2020 | Nuo Therapeutics, Inc. (AURX) | Chief Executive and Chief Financial Officer | — | $55,112 |
| 2019 | Nuo Therapeutics, Inc. (AURX) | Chief Executive and Chief Financial Officer | $91,667 | $140,543 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.